3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Penile Neoplasms
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Anus Neoplasms
1
Anatomic Stage III Breast Cancer AJCC v8
1
Interventions
Rituximab
28
acalabrutinib
15
ibrutinib
14
Cyclophosphamide
13
venetoclax
10
Lenalidomide
10
CT-P10
10
zanubrutinib
9
Magnetic Resonance Spectroscopy
8
obinutuzumab
7
fludarabine
7
Specimen Handling
7
Cytarabine
7
Bendamustine Hydrochloride
7
pirtobrutinib
6
Peripheral Blood Stem Cell Transplantation
6
Biopsy
6
glofitamab
5
fludarabine phosphate
5
Whole-Body Irradiation
5
Cyclosporine
5
brexucabtagene autoleucel
4
Mycophenolic Acid
4
Vincristine
3
Stem Cell Transplantation
3
Sirolimus
3
Methotrexate
3
Etoposide
3
Doxorubicin
3
Cyclosporins
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Mantle-Cell
×
entinostat
×
90 days
×
Clear all
No trials found.